United Nations University International Institute for Software Technology

AHF: Accountability is a Must for the Pandemic Agreement Talks

Retrieved on: 
Monday, November 6, 2023

At this time, the draft text of the agreement does not contain independent monitoring provisions and other effective compliance-enhancing mechanisms.

Key Points: 
  • At this time, the draft text of the agreement does not contain independent monitoring provisions and other effective compliance-enhancing mechanisms.
  • The pandemic agreement that is currently being negotiated by WHO member-states requires a robust accountability framework with independent monitoring to achieve its objectives.
  • This idea was echoed in the GPMB report, which has supported the integration of monitoring into the pandemic agreement governance structure that will eventually be established.
  • Do we need another pandemic to remind member states that we cannot continue with just another declaration full of general principles common in the pre-Covid19 pandemic era?” concluded Dr. Saavedra.

Centering Healthcare Institute Appoints Tammea S. Tyler as CEO

Retrieved on: 
Monday, August 7, 2023

Boston, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Centering Healthcare Institute (CHI), a national non-profit organization with a mission to improve health and transform the way care is delivered, announced today the appointment of Tammea S. Tyler, MSW/MBA as Chief Executive Officer.

Key Points: 
  • Boston, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Centering Healthcare Institute (CHI), a national non-profit organization with a mission to improve health and transform the way care is delivered, announced today the appointment of Tammea S. Tyler, MSW/MBA as Chief Executive Officer.
  • Under Tammea's stewardship, CHI will continue to focus on engaging multiple stakeholders to help them understand and recognize the importance of the Centering approach to transform the way that they deliver healthcare.
  • Andrea Darby-Stewart MD, CHI Board Chair, expressed great enthusiasm for the appointment of Tammea as the new Chief Executive.
  • “The Board is delighted to have appointed Tammea as our new Chief Executive.

Duas Rodas presents extracts, dehydrated ingredients and flavors produced under the Upcycling Food concept

Retrieved on: 
Tuesday, May 2, 2023

SÃO PAULO, May 2, 2023 /PRNewswire/ -- The circular economy concept is a key part of the sustainable development process applied to Duas Rodas' natural ingredients.

Key Points: 
  • SÃO PAULO, May 2, 2023 /PRNewswire/ -- The circular economy concept is a key part of the sustainable development process applied to Duas Rodas' natural ingredients.
  • These products are made under the Upcycling Food concept.
  • The company's portfolio includes extracts, dehydrated ingredients and flavors manufactured using by-products of plants and fruits that are normally discarded, thereby helping to reduce food waste.
  • "We operate as part of different innovation projects in partnership with national and international institutes, which are aligned with the Upcycling Food concept.

Joe Hartsig, Board Member and Fortune 500 Chief Merchandising Officer, joins Raines to lead Retail practice

Retrieved on: 
Tuesday, April 11, 2023

MIAMI, April 11, 2023 /PRNewswire-PRWeb/ -- Raines International announced today that Joe Hartsig, previously chief merchandising officer at Bed Bath & Beyond and Walgreens and a senior merchandising executive at Walmart, is joining the executive search and talent advisory firm as a Managing Director. He will lead Raines' Retail practice and is based in the Chicago office.

Key Points: 
  • He will lead Raines' Retail practice and is based in the Chicago office.
  • Hartsig has more than 30 years of experience in the retail and consumer goods sector, most recently serving as Chief Merchandising Officer at Bed Bath & Beyond and President of Harmon Stores.
  • Prior to Bed Bath & Beyond, he was Chief Merchandising Officer and head of Marketing at Walgreens and Chief Merchandising and Marketing Officer at Essendant, now part of Staples.
  • "The differentiated value proposition that Joe offers clients is undeniable and highly impactful," said Dan Smith, CEO of Raines International.

Dr. Nevine El-leithy Joins NeuroLight as its Chief Scientific Officer

Retrieved on: 
Monday, April 10, 2023

POMONA, N.Y., April 10, 2023 /PRNewswire-PRWeb/ -- NeuroLight, Inc., a neuromodulation company, today announced that Dr. Nevine El-leithy joined the team as its Chief Scientific Officer (CSO).

Key Points: 
  • NeuroLight, Inc., a neuromodulation company first to develop technology for transplanting brain states™, hires Dr. Nevine El-leithy as the Chief Scientific Officer (CSO).
  • Dr. Nevine El-leithy earned a Ph.D. in Neuroscience from Stanford University and a second Ph.D. in Biomedical Engineering from George Washington University.
  • "We are delighted to welcome Dr. El-leithy as the CSO," said Alexander Poltorak, the Founder and President of NeuroLight.
  • "I am pleased to join the team of NeuroLight, developing a groundbreaking neuromodulation technology to transplant brain states," said Dr. El-leithy.

Raines International Names Ceylan Higgins, Kiel Towns as Managing Directors, Kristin Mann as SVP

Retrieved on: 
Monday, January 9, 2023

Ceylan Higgins, previously a partner at True Search, joined the firm as a Managing Director.

Key Points: 
  • Ceylan Higgins, previously a partner at True Search, joined the firm as a Managing Director.
  • Based in Raines' London office, she will co-lead the Global Software & Technology Practice with Managing Directors Duncan Finlayson, also based in London, and Rick Harris, based in Miami.
  • Managing Director Patrick Gray, who relocated to London last summer to open Raines' London office, leads the Global Industrial Sector Practice.
  • Earlier this month, Kristin Mann joined Raines as Senior Vice President in Raines' Advisory Practice.

Debbie's Dream Foundation Celebrates a Successful Year of Serving the Stomach Cancer Community Through the Generous Support of Its 2022 Industry Partners

Retrieved on: 
Thursday, December 22, 2022

FORT LAUDERDALE, Fla., Dec. 22, 2022 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) celebrates a successful year of providing critical resources and support to the stomach cancer community. Much of the organization's success is due to the generosity of its 2022 industry partners. In 2022, DDF secured just over $1.6 million in support grants. As a result, the foundation has continued to serve patients, their families, and caregivers through its Patient Resource Education Program (PREP), National and International Symposia, Nutrition Program, and Health Equity Program.

Key Points: 
  • FORT LAUDERDALE, Fla., Dec. 22, 2022 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) celebrates a successful year of providing critical resources and support to the stomach cancer community.
  • Much of the organization's success is due to the generosity of its 2022 industry partners.
  • Through PREP, the foundation provides support and resources through peer-to-peer mentorship, clinical trial matching services, and monthly support groups in partnership with Memorial Cancer Institute.
  • DDF hosted nine Stomach Cancer Educational Webinars, three National Symposia, and one International Symposium in partnership with the Korean Cancer Association.

EQS-News: AiCuris Anti-infective Cures AG: AiCuris´ innovation accelerator AiCubator calls for innovative proposals to propel anti-infective drug development in the third round

Retrieved on: 
Thursday, September 29, 2022

AiCubator residents, over a period of up to three years, will benefit from the scientific know-how and drug development expertise of AiCuris - a leading company in anti-infectives with a product already on the market.

Key Points: 
  • AiCubator residents, over a period of up to three years, will benefit from the scientific know-how and drug development expertise of AiCuris - a leading company in anti-infectives with a product already on the market.
  • As part of the AiCubator program, residents learn how to transform great ideas into new products.
  • Interested parties can apply to the AiCubator program by filling in the AiCubator standard application form , describing the project, its status and development plans.
  • The focus of the initiative is on targeted antiviral and antibacterial therapies and applications in the following indications:

Cortexyme Appoints Dr. Philip Low to Its Board of Directors

Retrieved on: 
Friday, May 20, 2022

In conjunction with todays acquisition of Novosteo, we are very pleased to welcome a distinguished researcher, innovator, and entrepreneur of Dr. Philip Lows caliber to our Board of Directors, said David Lamond, chairman of Cortexymes Board of Directors.

Key Points: 
  • In conjunction with todays acquisition of Novosteo, we are very pleased to welcome a distinguished researcher, innovator, and entrepreneur of Dr. Philip Lows caliber to our Board of Directors, said David Lamond, chairman of Cortexymes Board of Directors.
  • The Cortexyme team and I share the same passion for challenging the status quo to deliver breakthrough therapeutics, said Dr. Philip Low.
  • Dr. Philip S. Low is the Presidential Scholar in Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.
  • Cortexyme, Inc. (Nasdaq: CRTX) is a clinical stage biopharmaceutical company dedicated to improving the lives of patients diagnosed with degenerative diseases.

Georgia Bio Names South Forsyth High School Junior as 2022 Georgia BioGENEius Winner

Retrieved on: 
Wednesday, April 13, 2022

Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge.

Key Points: 
  • Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge.
  • The BioGENEius Challenge is the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field.
  • While in San Diego, Mokshith will compete against high school students from the U.S., Canada, and Germany in the International BioGENEius Challenge.
  • The level of competition in Georgia was at an all-time high this year, said Georgia Bio President and CEO Maria Thacker.